Literature DB >> 7728177

Oral diadochokinesis in neurological dysarthrias.

H Ackermann1, I Hertrich, T Hehr.   

Abstract

Rapid syllable repetitions require alternating articulatory movements and, thus, provide a test for oral diadochokinesis. The present study performed an acoustic analysis of rapid syllable repetitions in patients suffering from idiopathic Parkinson's disease (n = 17), Huntington's chorea (n = 14), Friedreich's ataxia (n = 9), or from a purely cerebellar syndrome (n = 13). Four parameters were considered: the mean number of syllables per train, the median syllable duration with its variation coefficient, and articulatory imprecision in terms of the percentage of incomplete closures. Apart from a few subjects with minor motor deficits only, in all patients at least one of the four measures of diadochokinesis exceeded the normal range. Accordingly, discriminant analysis revealed a highly significant difference between controls and patients with respect to the considered parameters. Thus, oral diadochokinesis tasks represent a sensitive measure of orofacial motor impairment. Moreover, multivariate analysis showed that Parkinson's disease and Friedreich's ataxia are characterized by a highly specific profile of diadochokinesis performance.

Entities:  

Mesh:

Year:  1995        PMID: 7728177     DOI: 10.1159/000266338

Source DB:  PubMed          Journal:  Folia Phoniatr Logop        ISSN: 1021-7762            Impact factor:   0.849


  16 in total

Review 1.  Nonspeech Oral Movements and Oral Motor Disorders: A Narrative Review.

Authors:  Ray D Kent
Journal:  Am J Speech Lang Pathol       Date:  2015-11       Impact factor: 2.408

2.  Cognitive functions in patients with MR-defined chronic focal cerebellar lesions.

Authors:  Stefanie Richter; Marcus Gerwig; Bakiye Aslan; Hans Wilhelm; Beate Schoch; Albena Dimitrova; Elke R Gizewski; Wolfram Ziegler; Hans-Otto Karnath; Dagmar Timmann
Journal:  J Neurol       Date:  2007-03-22       Impact factor: 4.849

3.  A Standardized Protocol for Maximum Repetition Rate Assessment in Children.

Authors:  Sanne Diepeveen; Leenke van Haaften; Hayo Terband; Bert de Swart; Ben Maassen
Journal:  Folia Phoniatr Logop       Date:  2019-06-28       Impact factor: 0.849

4.  A Psycholinguistic Framework for Diagnosis and Treatment Planning of Developmental Speech Disorders.

Authors:  Hayo Terband; Ben Maassen; Edwin Maas
Journal:  Folia Phoniatr Logop       Date:  2019-07-03       Impact factor: 0.849

5.  Characteristics and occurrence of speech impairment in Huntington's disease: possible influence of antipsychotic medication.

Authors:  Jan Rusz; Jiří Klempíř; Tereza Tykalová; Eva Baborová; Roman Čmejla; Evžen Růžička; Jan Roth
Journal:  J Neural Transm (Vienna)       Date:  2014-05-09       Impact factor: 3.575

6.  Friedreich ataxia: dysarthria profile and clinical data.

Authors:  Bettina Brendel; Hermann Ackermann; Daniela Berg; Tobias Lindig; Theresa Schölderle; Ludger Schöls; Matthis Synofzik; Wolfram Ziegler
Journal:  Cerebellum       Date:  2013-08       Impact factor: 3.847

7.  Analysis of diadochokinesis in ataxic dysarthria using the motor speech profile program.

Authors:  Yu-Tsai Wang; Ray D Kent; Joseph R Duffy; Jack E Thomas
Journal:  Folia Phoniatr Logop       Date:  2008-12-17       Impact factor: 0.849

8.  Balance and motor speech impairment in essential tremor.

Authors:  Martin Kronenbuerger; Jürgen Konczak; Wolfram Ziegler; Paul Buderath; Benedikt Frank; Volker A Coenen; Karl Kiening; Peter Reinacher; Johannes Noth; Dagmar Timmann
Journal:  Cerebellum       Date:  2009-05-19       Impact factor: 3.847

9.  Association between masticatory ability and oral functions.

Authors:  Mariko Maruyama; Koji Morita; Hitomi Kimura; Fumiko Nishio; Mitsuyoshi Yoshida; Kazuhiro Tsuga
Journal:  J Clin Exp Dent       Date:  2020-11-01

Review 10.  The contribution of the cerebellum to speech production and speech perception: clinical and functional imaging data.

Authors:  Hermann Ackermann; Klaus Mathiak; Axel Riecker
Journal:  Cerebellum       Date:  2007       Impact factor: 3.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.